PMHNP Telehealth | Reviewed September 26, 2026
Telehealth Prescribing For PMHNPs (2026)
PMHNPs can prescribe non-controlled psychiatric medications by telehealth under their state’s rules. For controlled substances, the DEA and HHS extended the pandemic-era telemedicine flexibilities through December 31, 2026. Until then, a DEA-registered practitioner can prescribe Schedule II to V medications without a prior in-person evaluation if the rule’s conditions are met. Your state, and the state where the patient is, can still add stricter conditions, so it’s worth checking both.
Read This First
The Rules Move, So Check Two Sources
Few areas of federal health regulation move faster than telehealth prescribing of controlled substances. The DEA has extended the temporary flexibilities from the COVID-19 public health emergency more than once, and the permanent framework still isn’t published.
Before you prescribe anything by telehealth, and especially any controlled substance, confirm the current requirements with two primary sources: the U.S. Drug Enforcement Administration (DEA) and your own state board of nursing and state controlled-substance authority. This page is only as current as the review date at the top.
The Foundation
Non-Controlled Vs. Controlled: Two Different Conversations
It helps to separate two very different categories, because they are governed differently.
Non-Controlled Medications
Many psychiatric medications aren’t controlled substances, including a large share of antidepressants and other non-scheduled agents. Prescribing them by telehealth is usually simpler. Mostly, your state’s telehealth and scope-of-practice rules and the standard of care govern it, rather than the DEA’s controlled-substance framework. State requirements still apply, so check them.
Controlled Substances
Scheduled medications, including certain stimulants and other controlled agents used in psychiatry, sit under a separate and stricter federal framework tied to the Ryan Haight Act and DEA rules. That’s the part that’s actively changing, and it’s where you have to check the current requirements before you prescribe.
The rest of this page focuses on the controlled-substance side, because that is where the uncertainty and the risk concentrate. For non-controlled prescribing, your state board and standard-of-care expectations are the main references.
The Legal Backdrop
The Ryan Haight Act And Why It Matters
The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 is the federal law that historically shaped controlled-substance prescribing over the internet. Broadly, and with specific exceptions, it meant a practitioner generally needed at least one in-person medical evaluation of a patient before prescribing them a controlled substance remotely. That’s the baseline the pandemic-era flexibilities relaxed for a time. It’s why those flexibilities are called temporary exceptions, and why a permanent framework is being worked out.
That history helps, but it doesn’t replace the rules in force today. The exact scope of the statute, its exceptions and how it fits with today’s flexibilities are legal questions. Ask the DEA and qualified counsel how they apply to you. Don’t rely on a summary.
Where Things Stand
Where The Rules Stand (As Reviewed September 26, 2026)
Here’s where it stands on September 26, 2026. The DEA and HHS extended the pandemic-era telemedicine flexibilities a fourth time, and that extension runs through December 31, 2026. Under it, a DEA-registered practitioner can prescribe Schedule II to V controlled substances by telemedicine without a prior in-person evaluation, as long as the rule’s conditions are met. The permanent framework, a special registration for telemedicine, reached the White House for review as a final rule on August 25, 2026, and it hasn’t been published yet.
We’re not going to tell you whether a specific medication can be prescribed by telehealth for a specific patient. That depends on the rule’s conditions, your state and the drug, and the federal dates have moved more than once. We recheck this page every month. Before you prescribe, confirm the current status with the DEA and your state authorities that day.
Verify With The DEA
The DEA publishes the current federal rules, extensions, and any permanent framework as it is finalized. Check it directly, and note the effective dates on whatever you find.
Verify With Your State Board
Federal rules are a floor, not the whole picture. Your state board of nursing and state controlled-substance authority set additional requirements that can be stricter. Confirm both.
Re-Verify Over Time
Because a permanent framework is still evolving, treat this as something to re-check periodically, not a one-time confirmation. What is true this quarter may differ next quarter.
Fifty Different Answers
State-By-State Variation Is The Rule, Not The Exception
Even where a federal flexibility exists, your state may impose its own conditions, and states differ significantly. Variation shows up in several places at once.
| Area | What can vary by state |
|---|---|
| Scope of practice | Whether a PMHNP practices independently or under a collaborative or supervisory arrangement, which can affect prescribing authority. |
| Telehealth modality | Whether audio-video is required, and how audio-only encounters are treated for different services. |
| Establishing the relationship | What a state requires to establish a valid provider-patient relationship before prescribing via telehealth. |
| Controlled-substance limits | State-specific restrictions, prescription monitoring program checks, and record-keeping requirements that go beyond federal rules. |
| Patient location and licensure | Requirements tied to where the patient is physically located at the time of the visit, and licensure in that state. |
“Is this allowed?” almost always has a federal answer and a state answer, and both have to line up. When they conflict, the stricter rule generally wins. If you practice across state lines, it’s the state where each patient is located that you have to satisfy. Your home state’s rules alone aren’t enough.
Practical Posture
How To Operate Responsibly While The Rules Evolve
Build Verification Into Your Workflow
Make checking the current DEA and state requirements a documented step in your telehealth prescribing process, not an afterthought. Record the date you verified and the source.
Know Where Your Patient Is
Confirm the patient’s physical location at each visit, since licensure and prescribing rules can hinge on the state the patient is in, not where you are.
Document To The Standard Of Care
Strong clinical documentation supports appropriate prescribing regardless of how rules shift. Meeting the standard of care is expected of you either way.
Get Professional Guidance
For your specific situation, especially involving controlled substances across states, consult qualified healthcare counsel and your state board rather than relying on general summaries.
If you’re still setting up the practice, telehealth is one piece of a bigger setup that also includes your business, credentialing and billing. Our guide to starting a PMHNP practice and the 90-day launch checklist put telehealth in that broader context, PMHNP credentialing covers the enrollment side, and our PMHNP practice resources tie the pieces together.
Common Questions
Frequently Asked Questions
Can A PMHNP Prescribe Controlled Substances Via Telehealth Right Now?
Yes, through December 31, 2026, as long as you meet the conditions of the extended DEA telemedicine flexibilities. Under them, a DEA-registered practitioner can prescribe Schedule II to V controlled substances by telemedicine without a prior in-person evaluation. State rules still apply. The federal date has moved before, too, so it’s worth checking the DEA and your state board on the day you prescribe.
Is Prescribing Non-Controlled Psychiatric Medications By Telehealth Simpler?
Generally yes. Non-controlled medications are not governed by the DEA’s controlled-substance framework, so they are primarily subject to your state’s telehealth and scope-of-practice rules and the standard of care. You still need to verify and follow your state’s requirements.
Did The Pandemic-Era Telehealth Prescribing Flexibilities Expire?
No. As of our September 26, 2026 review, the DEA and HHS had extended them a fourth time, through December 31, 2026. The permanent framework, a special registration for telemedicine, reached White House review as a final rule on August 25, 2026, and hadn’t been published yet. Check the DEA for the current dates.
What Is The Ryan Haight Act In Plain Terms?
It’s the 2008 federal law that, with exceptions, generally set an in-person evaluation requirement before prescribing controlled substances remotely. It’s the baseline the temporary flexibilities relaxed. How it applies to you is a legal question for qualified counsel.
Do Federal Rules Or My State’s Rules Control?
Both apply, and they must line up. Federal rules set a floor; states can add stricter requirements. When they differ, the stricter one generally governs, and you must satisfy the rules of the state where the patient is located.
Where Should I Check For The Current Rules?
Start with the DEA at dea.gov for the federal picture, then your state board of nursing and state controlled-substance authority for state requirements. Re-verify periodically, since the permanent framework is still evolving.
Adding Telehealth Patients In Another State?
Licensure follows the patient, and so does payer enrollment. A new state can mean a new Medicaid enrollment and new commercial applications before those visits get paid. We prepare and track them. Medicare or Medicaid enrollment is $450 each, and you can price commercial payers one at a time in the same builder.
This is general information, not legal, medical, billing or tax advice. Telehealth prescribing rules change, especially for controlled substances, and they vary by state. Check the current requirements directly with the DEA (https://www.dea.gov/) and your state board of nursing and controlled-substance authority, and talk to qualified counsel about your situation. Last reviewed: July 2026.